Investor Insights

This summary was created by AI, based on 2 opinions in the last 12 months.

Natera (NTRA-Q) has experienced significant momentum, evidenced by a remarkable 145% increase over the past year. Analysts praise the company's strong positioning in the cancer detection and recurrence testing market, indicating that it possesses a robust franchise in these critical areas. Furthermore, one expert has recently acquired shares, suggesting confidence in the company's growth trajectory and its ability to achieve cash-flow positivity within the year. Overall, both reviews reflect a sense of optimism and long-term faith in Natera's potential to deliver value to shareholders through its innovative biotech solutions in cancer testing.

Consensus
Positive
Valuation
Fair Value
Similar
Exactech, EXAC
PARTIAL SELL

Trimmed it because it moved up 145% the past year. They have a great franchise in cancer detection recurrence. Likes it long-term.

Healthcare
BUY

A biotech that does, among other things, cancer testing which is very accurate.. She just bought it. Is growing fast and expects it to be cash-flow positive this year.

Healthcare
BUY
He believes in this space, diagnostics. NTRA can make an acquiring company a nice piece of change.
Healthcare
Showing 1 to 3 of 3 entries
  • «
  • 1
  • »

Natera(NTRA-Q) Rating

Ranking : 3 out of 5

Bullish - Buy Signals / Votes : 1

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 1

Total Signals / Votes : 2

Stockchase rating for Natera is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Natera(NTRA-Q) Frequently Asked Questions

What is Natera stock symbol?

Natera is a American stock, trading under the symbol NTRA-Q on the NASDAQ (NTRA). It is usually referred to as NASDAQ:NTRA or NTRA-Q

Is Natera a buy or a sell?

In the last year, 2 stock analysts published opinions about NTRA-Q. 1 analyst recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Natera.

Is Natera a good investment or a top pick?

Natera was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Natera.

Why is Natera stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Natera worth watching?

2 stock analysts on Stockchase covered Natera In the last year. It is a trending stock that is worth watching.

What is Natera stock price?

On 2025-02-12, Natera (NTRA-Q) stock closed at a price of $171.88.